These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Efficacy of amiodarone for preventing the recurrence of symptomatic paroxysmal and persistent atrial fibrillation after cardioversion. Komatsu T, Tachibana H, Sato Y, Ozawa M, Nakamura M, Okumura K. Circ J; 2007 Jan; 71(1):46-51. PubMed ID: 17186977 [Abstract] [Full Text] [Related]
27. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation. Frick M, Darpö B, Ostergren J, Rosenqvist M. Eur Heart J; 2000 Jul; 21(14):1177-85. PubMed ID: 10924301 [Abstract] [Full Text] [Related]
29. Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial. Kirchhof P, Andresen D, Bosch R, Borggrefe M, Meinertz T, Parade U, Ravens U, Samol A, Steinbeck G, Treszl A, Wegscheider K, Breithardt G. Lancet; 2012 Jul 21; 380(9838):238-46. PubMed ID: 22713626 [Abstract] [Full Text] [Related]
30. P wave dispersion and short-term vs. late atrial fibrillation recurrences after cardioversion. Boriani G, Diemberger I, Biffi M, Camanini C, Valzania C, Corazza I, Martignani C, Zannoli R, Branzi A. Int J Cardiol; 2005 Jun 08; 101(3):355-61. PubMed ID: 15907401 [Abstract] [Full Text] [Related]
35. Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation. Hemels ME, Van Noord T, Crijns HJ, Van Veldhuisen DJ, Veeger NJ, Bosker HA, Wiesfeld AC, Van den Berg MP, Ranchor AV, Van Gelder IC. J Am Coll Cardiol; 2006 Sep 05; 48(5):1001-9. PubMed ID: 16949494 [Abstract] [Full Text] [Related]
36. Effects of chronic omega-3 polyunsaturated fatty acid supplementation on human pulmonary vein and left atrial electrophysiology in paroxysmal atrial fibrillation. Kumar S, Sutherland F, Teh AW, Heck PM, Lee G, Garg ML, Sparks PB. Am J Cardiol; 2011 Aug 15; 108(4):531-5. PubMed ID: 21624541 [Abstract] [Full Text] [Related]
37. Comparison of atrial fibrillation recurrence rates after successful electrical cardioversion in patients with hyperthyroidism-induced versus non-hyperthyroidism-induced persistent atrial fibrillation. Siu CW, Jim MH, Zhang X, Chan YH, Pong V, Kwok J, Kung AW, Lau CP, Tse HF. Am J Cardiol; 2009 Feb 15; 103(4):540-3. PubMed ID: 19195517 [Abstract] [Full Text] [Related]
38. [Effects of pretreatment with amiodarone infusion in patients with persistent atrial fibrillation submitted to external electrical cardioversion: a single center experience]. Maffè S, Paffoni P, Perucca A, Dellavesa P, Parravicini U, Nicali R, Bielli M, Paino AM, Signorotti F, Franchetti Pardo N, Zenone F, Zanetta M. G Ital Cardiol (Rome); 2008 Jul 15; 9(7):504-8. PubMed ID: 18678217 [Abstract] [Full Text] [Related]
40. Continuous vs episodic prophylactic treatment with amiodarone for the prevention of atrial fibrillation: a randomized trial. Ahmed S, Rienstra M, Crijns HJ, Links TP, Wiesfeld AC, Hillege HL, Bosker HA, Lok DJ, Van Veldhuisen DJ, Van Gelder IC, CONVERT Investigators. JAMA; 2008 Oct 15; 300(15):1784-92. PubMed ID: 18854540 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]